Browsing Harvard Medical School by Keyword "Histone deacetylase inhibitor"
Now showing items 1-1 of 1
-
Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer
(BioMed Central, 2016)Background: Pre-clinical studies have demonstrated that natural and synthetic histone deacetylase (HDAC) inhibitors can impede the in vitro and in vivo growth of cell lines from a variety of gynecologic and other malignancies. ...